Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T20:43:27.608Z.
Calculation as of: 2026-10-06T20:43:27.608Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a58e0fcb5c5c5211a6c4e1a8bb78ffa34e5085398ec1b7e8aba4a6f7bffe7660
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-05-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
30.34x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Unicycive Therapeutics, Inc.
Market Cap
$112.94M
EV/Sales Ratio
N/A
TTM Avg
30.34x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$112.57M
EV/Sales Ratio
11.26x
TTM Avg
18.19x
3Y Avg
13.45x
5Y Avg
23.44x
Market Cap
$113.77M
EV/Sales Ratio
N/A
TTM Avg
52.04x
3Y Avg
28.07x
5Y Avg
28.07x
Market Cap
$113.89M
EV/Sales Ratio
13391.33x
TTM Avg
11863.26x
3Y Avg
8138.14x
5Y Avg
6150.74x
Market Cap
$114.46M
EV/Sales Ratio
19.46x
TTM Avg
23.83x
3Y Avg
20.50x
5Y Avg
102.56x
Market Cap
$110.30M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$115.67M
EV/Sales Ratio
2.47x
TTM Avg
9.70x
3Y Avg
9.36x
5Y Avg
78.10x
Market Cap
$109.14M
EV/Sales Ratio
56.29x
TTM Avg
54.20x
3Y Avg
33.22x
5Y Avg
26.89x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | $112.94M | N/A | 30.34x | N/A | N/A |
| Caribou Biosciences, Inc. (CRBU)vs › | $112.57M | 11.26x | 18.19x | 13.45x | 23.44x |
| Coya Therapeutics, Inc. (COYA)vs › | $113.77M | N/A | 52.04x | 28.07x | 28.07x |
| Genelux Corporation (GNLX)vs › | $113.89M | 13391.33x | 11863.26x | 8138.14x | 6150.74x |
| Lucid Diagnostics Inc. (LUCD)vs › | $114.46M | 19.46x | 23.83x | 20.50x | 102.56x |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | N/A | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | 2.47x | 9.70x | 9.36x | 78.10x |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | 56.29x | 54.20x | 33.22x | 26.89x |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 3.83x | 3.87x | 7.07x | 9.90x |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | N/A | 52.14x | 28.39x | 28.39x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2024-05-13 | 42.95x |
| 2024-05-10 | 45.01x |
| 2024-05-09 | 42.44x |
| 2024-05-08 | 45.01x |
| 2024-05-07 | 46.56x |
| 2024-05-06 | 47.59x |
| 2024-05-03 | 44.50x |
| 2024-05-02 | 44.50x |
| 2024-05-01 | 45.53x |
| 2024-04-30 | 44.50x |
| 2024-04-29 | 49.65x |
| 2024-04-26 | 39.86x |
| 2024-04-25 | 36.78x |
| 2024-04-24 | 40.38x |
| 2024-04-23 | 41.92x |
| 2024-04-22 | 46.04x |
| 2024-04-19 | 41.92x |
| 2024-04-18 | 42.95x |
| 2024-04-17 | 46.56x |
| 2024-04-16 | 44.50x |
| 2024-04-15 | 45.53x |
| 2024-04-12 | 49.65x |
| 2024-04-11 | 51.19x |
| 2024-04-10 | 53.77x |
| 2024-04-09 | 54.80x |
| 2024-04-08 | 58.40x |
| 2024-04-05 | 59.95x |
| 2024-04-04 | 62.01x |
| 2024-04-03 | 57.37x |
| 2024-04-02 | 57.89x |
| 2024-04-01 | 59.43x |
| 2024-03-28 | 46.75x |
| 2024-03-27 | 50.62x |
| 2024-03-26 | 50.13x |
| 2024-03-25 | 53.52x |
| 2024-03-22 | 51.10x |
| 2024-03-21 | 44.33x |
| 2024-03-20 | 48.68x |
| 2024-03-19 | 47.23x |
| 2024-03-18 | 49.16x |
| 2024-03-15 | 50.62x |
| 2024-03-14 | 49.65x |
| 2024-03-13 | 47.23x |
| 2024-03-12 | 49.16x |
| 2024-03-11 | 52.07x |
| 2024-03-08 | 53.52x |
| 2024-03-07 | 52.55x |
| 2024-03-06 | 54.00x |
| 2024-03-05 | 51.10x |
| 2024-03-04 | 52.07x |
| 2024-03-01 | 57.38x |
| 2024-02-29 | 46.75x |
| 2024-02-28 | 48.20x |
| 2024-02-27 | 52.55x |
| 2024-02-26 | 56.42x |
| 2024-02-23 | 66.57x |
| 2024-02-22 | 64.64x |
| 2024-02-21 | 59.32x |
| 2024-02-20 | 50.62x |
| 2024-02-16 | 46.26x |
| 2024-02-15 | 43.36x |
| 2024-02-14 | 36.11x |
| 2024-02-13 | 30.79x |
| 2024-02-12 | 30.79x |
| 2024-02-09 | 33.69x |
| 2024-02-08 | 35.14x |
| 2024-02-07 | 35.63x |
| 2024-02-06 | 32.73x |
| 2024-02-05 | 28.38x |
| 2024-02-02 | 25.14x |
| 2024-02-01 | 26.44x |
| 2024-01-31 | 25.96x |
| 2024-01-30 | 24.99x |
| 2024-01-29 | 25.48x |
| 2024-01-26 | 22.33x |
| 2024-01-25 | 24.99x |
| 2024-01-24 | 26.44x |
| 2024-01-23 | 27.55x |
| 2024-01-22 | 20.21x |
| 2024-01-19 | 21.95x |
| 2024-01-18 | 21.61x |
| 2024-01-17 | 22.82x |
| 2024-01-16 | 23.06x |
| 2024-01-12 | 20.64x |
| 2024-01-11 | 23.30x |
| 2024-01-10 | 27.41x |
| 2024-01-09 | 28.38x |
| 2024-01-08 | 24.99x |
| 2024-01-05 | 20.64x |
| 2024-01-04 | 20.16x |
| 2024-01-03 | 21.12x |
| 2024-01-02 | 22.87x |
| 2023-12-29 | 21.99x |
| 2023-12-28 | 22.33x |
| 2023-12-27 | 14.55x |
| 2023-12-26 | 9.04x |
| 2023-12-22 | 8.07x |
| 2023-12-21 | 7.59x |
| 2023-12-20 | 7.83x |
| 2023-12-19 | 8.99x |
| 2023-12-18 | 8.55x |
| 2023-12-15 | 7.68x |
| 2023-12-14 | 8.07x |
| 2023-12-13 | 10.01x |
| 2023-12-12 | 8.02x |
| 2023-12-11 | 10.01x |
| 2023-12-08 | 9.76x |
| 2023-12-07 | 8.07x |
| 2023-12-06 | 5.61x |
| 2023-12-05 | 6.62x |
| 2023-12-04 | 3.82x |
| 2023-12-01 | 3.72x |
| 2023-11-30 | 4.30x |
| 2023-11-29 | 4.74x |
| 2023-11-28 | 6.14x |
| 2023-11-27 | 7.20x |
| 2023-11-24 | 9.28x |
| 2023-11-22 | 8.07x |
| 2023-11-21 | 4.30x |
| 2023-11-20 | 5.17x |
| 2023-11-17 | 4.35x |
| 2023-11-16 | 4.83x |
| 2023-11-15 | 5.32x |
| 2023-06-29 | 1.10x |
| 2023-06-28 | 1.66x |
| 2023-06-27 | 1.20x |
| 2023-06-26 | 1.48x |
| 2023-06-15 | 0.45x |
| 2023-06-14 | 0.63x |
| 2023-06-13 | 1.20x |
| 2023-06-12 | 1.57x |
| 2023-06-09 | 2.04x |
| 2023-06-08 | 0.17x |
| 2023-06-06 | 0.35x |
| 2023-06-05 | 0.45x |
| 2023-05-16 | 21.68x |
| 2023-05-15 | 22.64x |
| 2023-05-12 | 21.84x |
| 2023-05-11 | 23.28x |
| 2023-05-10 | 23.76x |
| 2023-05-09 | 24.08x |
| 2023-05-08 | 23.28x |
| 2023-05-05 | 21.19x |
| 2023-05-04 | 20.87x |
| 2023-05-03 | 19.59x |
| 2023-05-02 | 20.07x |
| 2023-05-01 | 19.91x |
| 2023-04-28 | 20.55x |
| 2023-04-27 | 21.03x |
| 2023-04-26 | 21.52x |
| 2023-04-25 | 23.44x |
| 2023-04-24 | 24.88x |
| 2023-04-21 | 26.00x |
| 2023-04-20 | 25.52x |
| 2023-04-19 | 26.96x |
| 2023-04-18 | 27.28x |
| 2023-04-17 | 27.76x |
| 2023-04-14 | 28.08x |
| 2023-04-13 | 29.68x |
| 2023-04-12 | 29.84x |
| 2023-04-11 | 33.53x |
| 2023-04-10 | 32.89x |
| 2023-04-06 | 32.89x |
| 2023-04-05 | 33.85x |
| 2023-04-04 | 34.65x |
| 2023-04-03 | 35.45x |
| 2023-03-31 | 33.37x |
| 2023-03-30 | 22.61x |
| 2023-03-29 | 23.08x |
| 2023-03-28 | 20.07x |
| 2023-03-27 | 19.76x |
| 2023-03-24 | 23.08x |
| 2023-03-23 | 21.82x |
| 2023-03-22 | 27.68x |
| 2023-03-21 | 28.47x |
| 2023-03-20 | 27.52x |
| 2023-03-17 | 25.93x |
| 2023-03-16 | 27.04x |
| 2023-03-15 | 27.83x |
| 2023-03-14 | 27.83x |
| 2023-03-13 | 27.20x |
| 2023-03-10 | 35.28x |
| 2023-03-09 | 25.46x |
| 2023-03-08 | 18.49x |
| 2023-03-07 | 16.59x |
| 2023-03-06 | 12.47x |
| 2023-03-03 | 0.59x |
| 2023-03-02 | 0.75x |
| 2023-03-01 | 0.70x |
| 2023-02-28 | 1.02x |
| 2023-02-27 | 0.29x |
| 2023-02-24 | 0.44x |
| 2023-02-23 | 0.55x |
| 2023-02-22 | 0.99x |
| 2023-02-21 | 1.23x |
| 2023-02-17 | 1.23x |
| 2023-02-16 | 1.12x |
| 2023-02-15 | 1.70x |
| 2023-02-14 | 1.39x |
| 2023-02-13 | 1.54x |
| 2023-02-10 | 1.54x |
| 2023-02-09 | 0.91x |
| 2023-02-08 | 1.39x |
| 2023-02-07 | 1.59x |
| 2023-02-06 | 1.23x |
| 2023-02-03 | 1.20x |
| 2023-02-02 | 0.91x |
| 2023-02-01 | 1.53x |
| 2023-01-31 | 1.70x |
| 2023-01-30 | 1.50x |
| 2023-01-27 | 1.70x |
| 2023-01-26 | 2.48x |
| 2023-01-25 | 2.49x |
| 2023-01-24 | 2.49x |
| 2023-01-23 | 2.48x |
| 2023-01-20 | 1.99x |
| 2023-01-19 | 1.23x |
| 2023-01-18 | 1.26x |
| 2023-01-17 | 1.54x |
| 2023-01-13 | 0.72x |
| 2023-01-12 | 1.43x |
| 2023-01-11 | 1.40x |
| 2023-01-10 | 0.67x |
| 2023-01-04 | 0.48x |
| 2023-01-03 | 0.75x |
| 2022-12-30 | 1.39x |
| 2022-12-29 | 1.70x |
| 2022-12-28 | 0.75x |
| 2022-12-27 | 3.44x |
| 2022-12-23 | 3.75x |
| 2022-12-22 | 4.39x |
| 2022-12-21 | 3.90x |
| 2022-12-20 | 3.76x |
| 2022-12-19 | 3.86x |
| 2022-12-16 | 4.08x |
| 2022-12-15 | 4.00x |
| 2022-12-14 | 4.00x |
| 2022-12-13 | 4.47x |
| 2022-12-12 | 4.55x |
| 2022-12-09 | 4.68x |
| 2022-12-08 | 4.38x |
| 2022-12-07 | 4.35x |
| 2022-12-06 | 4.00x |
| 2022-12-05 | 4.13x |
| 2022-12-02 | 3.92x |
| 2022-12-01 | 4.32x |
| 2022-11-30 | 4.11x |
| 2022-11-29 | 4.24x |
| 2022-11-28 | 3.29x |
| 2022-11-25 | 3.44x |
| 2022-11-23 | 4.35x |
| 2022-11-22 | 4.32x |
| 2022-11-21 | 4.71x |
| 2022-11-18 | 4.55x |
| 2022-11-17 | 4.39x |
| 2022-11-16 | 3.76x |
| 2022-11-15 | 3.92x |
